Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 5:08 AM
Ignite Modification Date:
2025-12-25 @ 5:08 AM
NCT ID:
NCT03670927
Eligibility Criteria:
Inclusion Criteria:
* Cases
* Patients diagnosed in the previous 6 months from identification with a primary and histologically confirmed malignant sarcoma including soft-tissue, visceral and bone sarcomas as defined by the WHO classification of bones and soft tissue sarcoma, fourth edition, 2013;
* Diagnosed over a three-year period with an inclusion start date ranging from the 1st October 2018 to the 1st January 2020;
* Living in the 15 districts participating to the study at the time of diagnosis
* French nationality (due to control selection within electoral lists);
* At least 18 years old at diagnosis;
* Agreed to participate to the study with a signed informed consent;
* Controls
* Subjects registered within the electoral rolls;
* At least 18 years old at interview;
* Living in the 15 districts participating to the study at the time of interview;
* Agreed to participate to the study with a signed informed consent;
Exclusion Criteria:
* Cases
* Patients with a known genetic predisposition to sarcoma such as Li-Fraumeni syndrome, Retinoblastoma syndrome, neurofibromatosis;
* Kaposi's' sarcoma;
* Protected adults' patients (aged of at least 18 years old) under guardianship by court order.
* Controls
* Subject previously diagnosed with a primary and histologically confirmed malignant sarcoma including soft-tissue, visceral and bone sarcomas as defined by the WHO classification of bones and soft tissue sarcoma, fourth edition, 2013;
* Protected adults' patients (aged of at least 18 years old) under guardianship by court order.
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT03670927
Study Brief:
Protocol Section:
NCT03670927